Clinical Significance of Alpha-Fetoprotein in Alpha-Fetoprotein Negative Hepatocellular Carcinoma Underwent Curative Resection

[1] Torre LA(2015)Global cancer statistics, 2012 CA Cancer J Clin 65 87-108

[2] Bray F(2016)A review and update of treatment options and controversies in the management of hepatocellular carcinoma Ann Surg 263 1112-1125

[3] Siegel RL(2018)Electronic address eee, European Association for the Study of the L: eASL Clinical Practice Guidelines: Management of hepatocellular carcinoma J Hepatol 69 182-236

[4] Ferlay J(2019)Biology and significance of alpha-fetoprotein in hepatocellular carcinoma Liver Int 39 2214-2229

[5] Lortet-Tieulent J(2010)Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study J Hepatol 52 880-888

[6] Jemal A(2018)Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection J Hepatol 69 1284-1293

[7] Dhir M(2019)Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased alpha-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial Lancet Oncol 20 282-296

[8] Melin AA(2018)42,573 cases of hepatectomy in China: a multicenter retrospective investigation Sci China Life Sci 61 660-670

[9] Douaiher J(2019)Prognostic value of preoperative alpha-fetoprotein (AFP) level in patients receiving curative hepatectomy- an analysis of 1,182 patients in Hong Kong Transl Gastroenterol Hepatol 4 52-724

[10] Lin C(2010)Prognosis evaluation in alpha-fetoprotein negative hepatocellular carcinoma after hepatectomy: comparison of five staging systems Eur J Surg Oncol 36 718-1547

[1] Torre LA(2015)Global cancer statistics, 2012 CA Cancer J Clin 65 87-108

[2] Bray F(2016)A review and update of treatment options and controversies in the management of hepatocellular carcinoma Ann Surg 263 1112-1125

[3] Siegel RL(2018)Electronic address eee, European Association for the Study of the L: eASL Clinical Practice Guidelines: Management of hepatocellular carcinoma J Hepatol 69 182-236

[4] Ferlay J(2019)Biology and significance of alpha-fetoprotein in hepatocellular carcinoma Liver Int 39 2214-2229

[5] Lortet-Tieulent J(2010)Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study J Hepatol 52 880-888

[6] Jemal A(2018)Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection J Hepatol 69 1284-1293

[7] Dhir M(2019)Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased alpha-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial Lancet Oncol 20 282-296

[8] Melin AA(2018)42,573 cases of hepatectomy in China: a multicenter retrospective investigation Sci China Life Sci 61 660-670

[9] Douaiher J(2019)Prognostic value of preoperative alpha-fetoprotein (AFP) level in patients receiving curative hepatectomy- an analysis of 1,182 patients in Hong Kong Transl Gastroenterol Hepatol 4 52-724

[10] Lin C(2010)Prognosis evaluation in alpha-fetoprotein negative hepatocellular carcinoma after hepatectomy: comparison of five staging systems Eur J Surg Oncol 36 718-1547